Chemistry World: More Than a Mirror-Image: Left-Handed Nucleic Acids

Two double helixes of DNA, one appears normal and the other appears jagged and damaged.
February 20, 2024
The Division of Pharmacology & Toxicology's Karen Vasquez, Ph.D. talked to Chemistry World's Rachel Brazil on genetic instability in disease and evolution of course related to Z-DNA. Dr. Vasquez's research focuses on genome instability, DNA damage and mechanisms of repair.

FDA Considers Making Narcan Opioid Overdose Antidote Available Without Prescription

Two hands cradling a nasal spray dispenser for naloxone.
February 15, 2023
Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.

Vasquez Writes in Nature Reviews Genetics on Alternative DNA Structures

"Nature Reviews Genetics" written inside of a circle.
November 1, 2022
Division Head and Professor of Pharmacology & Toxicology Karen Vasquez, Ph.D. published in the latest issues of Nature Reviews Genetics regarding repetitive elements in the human genome. Once considered "junk DNA," they are now known to adopt more than a dozen alternative DNA structures. These dynamic conformations can act as functional genomic elements involved in DNA replication and transcription, chromatin organization and genome stability.

Faculty Earn State Grants for Cancer Research

A person in a lab.
September 21, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

Reveles and Evoy Earn Promotions

A woman and a man smiling.
February 25, 2022
Two of the college's distinguished faculty in the Division of Pharmacotherapy were recommended for promotion by President Hartzell. Dr. Kelly R. Reveles will assume the rank of associate professor and Dr. Kirk Evoy will become a clinical associate professor. Both promotions go into effect September 1, 2022.

Vasquez Appears on BBC World Service to Discuss Z-DNA

DNA.
June 16, 2021
Division Head and Professor of Pharmacology and Toxicology Karen Vasquez, Ph.D. appeared on BBC World Service's Science in Action to talk about Z-DNA. Dr. Vasquez's research focuses on DNA damage and repair, genomic instability, gene targeting, DNA structure and cancer therapeutics.

TxCORE Research Wins PhRMA Foundation Award

Three people smiling.
April 1, 2021
Three researchers from the College of Pharmacy won an award from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. Leticia R. Moczygemba, Pharm.D., Ph.D., Carolyn M. Brown, Ph.D. and Michael Johnsrud, Ph.D., R.Ph. were awarded $5,000 from the PhRMA Foundation for their proposal to advance racial and ethnic representation in value assessments.

Kompella Receives Fulbright Award for Postdoctoral Research

A woman smiling.
March 16, 2021
Division of Pharmacology and Toxicology researcher Pallavi Kompella, Ph.D. has received a Fulbright U.S. Scholar Program award to research at the Biomedical Research Institute of Málaga in Spain.

In Remembrance of Dr. Ted Mills

A man wearing a suit and tie.
October 23, 2020
It is with great sadness that we announce the passing of Edward (Ted) Mills, Ph.D., associate professor in the Division of Pharmacology and Toxicology and Bergen Brunswig Corporation Centennial Fellow.

Vasquez collaborates on paper published in Nature

Karen Vasquez headshot
August 3, 2018
College of Pharmacy Professor Karen M. Vasquez, Ph.D. recently collaborated on a research paper exploring the mechanisms involved in DNA structure-induced genetic instability in human disease. “Mechanisms of genetic instability caused by (CGG)n repeats in an experimental mammalian system” recently published in Nature, and includes co-authors Artem V. Kononenko, Thomas Ebersole, and Sergei M. Mirkin from Tufts University.